USPTO serial 79414175
GRAFALON
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 10, 2026
- Examiner
- O'BRIEN, JENNIFER LYNN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with GRAFALON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Patrick F. Clunk
Patrick F. Clunk Tucker Ellis LLP950 Main Ave, Suite 1100Cleveland, OH 44113United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical compositions and preparations, namely, pharmaceutical preparations for the treatment of anti-neutrophil cytoplasmic antibody associated vasculitis, aplastic anemia, autoimmune diseases, diabetes, and for the prevention and treatment of graft-versus-host disease, hemophagocytic lymphohistiocytosis, lupus nephritis, multiple sclerosis, myelodysplastic syndrome, myelofibrosis, systemic lupus erythematosus, as well as for use in organ and tissue transplantation; biopharmaceutical compositions and preparations, in particular those for use in the treatment of immunological conditions, tissue, stem cell and organ transplants, tumors and immune system conditions; medicinal preparations for the treatment of infectious diseases and for use in oncology and hematology; medicinal preparations for use in stem cell transplant procedures; medicinal preparations for use in organ transplant procedures. | ACTIVE | — |
| 042 | Scientific services and research for medical purposes, namely medical and scientific research in the field of cell biology and antibodies and immunology; scientific and technological services, namely scientific research, analysis, testing in the field of biotechnology, biopharmaceutics and medical science; biotechnological and biopharmaceutical analyses, namely blood analysis services for scientific research purpose, cell analysis services for scientific research purpose, DNA analysis services for scientific research purpose, human leukocyte antigen (HLA) analysis services for scientific research purpose , antibodies analysis services for scientific research purpose, antigen analysis services for scientific research purposes, Technical research in the field of pharmaceutical studies; medical research laboratory services. | ACTIVE | — |
| 044 | Medical services; medical, pharmaceutical and biopharmaceutical services in the nature of medical and pharmaceutical consultation and medical advice and information in the field of oncology, hematology, stem cell transplantation, organ transplantation and immunological therapy. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Neovii Biotech GmbH
- Other trademarks owned by Neovii Biotech GmbH
- Other trademarks owned by Neovii Biotech GmbH
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named GRAFALON
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 10, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 25, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 24, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 18, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 10, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 1, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 31, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 10, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 10, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 20, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 20, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 14, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 19, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 18, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 18, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 18, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 18, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 24, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 24, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 24, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 8, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 24, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 24, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 1, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 31, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 28, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 11, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 11, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 2, 2025 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |